HIV-vaccine trial halted after review board finds no effect

“These results do not change the fundamental view that an AIDS vaccine remains critical to any long-term strategy to end the AIDS epidemic.”

Matthew Rose, a D.C. participant in the HVTN 505 HIV-vaccine trial, which was halted today. The trial was called off after an independent review board found the vaccine neither prevented HIV infections nor reduced the amount of HIV in people infected with virus. The trial focused specifically on gay and bisexual men, and men who otherwise have sex with men, and transgender people. (Reuters

Follow Will O'Bryan on Twitter @wobryan.

Feed Your Email!

Metro Weekly emails are a great way to stay up-to-date with everything you need to know. Join our 12,000 subscribers and get the best in LGBT news, arts and entertainment reviews, contests, exclusive coverboy and nightlife content, and much, much more delivered directly to your inbox!

  • The Feed: Our Daily Round Up
  • Spotlight: Arts, Entertainment, Dining
  • Happy Hour: Photo of the Day, Drink Specials, DJ Top 10s
  • Coverboy Extra: Even more of what you love about Coverboy
  • Spree: Sales, Gifts, Deals, Special Offers
  • Fun & Games: Contests, Polls and More!

Feed Your Email!

Metro Weekly emails are a great way to stay up-to-date with everything you need to know. Join our 12,000 subscribers and get the best in LGBT news, arts and entertainment reviews, contests, exclusive coverboy and nightlife content, and more delivered directly to your inbox!

  • The Feed: Our daily round-up of things you need to know
  • Spotlight: Arts, Entertainment, Reviews
  • Fun & Games: Contests, Polls, More
  • Happy Hour: Photo of the Day, Drink Specials, Top Tens
  • Coverboy Extra: Even more of what you love about Coverboy!
  • Spree: Shopping, Gifts, Bargains, Special Offers